Forte Biosciences, Inc.
FBRXDelisted Aug 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419041
Forte Biosciences, Inc. was delisted on Aug 27, 2026; its insiders filed their last Form 4 on Aug 27, 2026; 86 institutions reported holding it in 13F filings for Q2 2026, worth $432.7M in total; no superinvestor held it.
Q3 2025 vs. Q2 2025
How the institutions holding Forte Biosciences, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 34 | 42 | +8 |
| Shares | 10.1M | 10.3M | +272.3K (+2.7%) |
| Value | $130.4M | $155.1M | +$24.6M (+18.9%) |
New holders (12)
Institutions that held Forte Biosciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FMR LLC | 244,400 | $3.67M | 0.00% |
| Ameriprise Financial Inc | 69,892 | $1.05M | 0.00% |
| State Street Corp | 38,097 | $571.5K | 0.00% |
| Northern Trust Corp | 23,285 | $349.3K | 0.00% |
| Marshall Wace, LLP | 19,165 | $287.5K | 0.00% |
| Renaissance Technologies LLC | 16,200 | $243.0K | 0.00% |
| Citadel Advisors LLC | 15,633 | $234.5K | 0.00% |
| Dimensional Fund Advisors LP | 10,765 | $161.0K | 0.00% |
| Barclays PLC | 820 | $12.3K | 0.00% |
| Steward Partners Investment Advisory, LLC | 553 | $8.29K | 0.00% |
| Tower Research Capital LLC (TRC) | 162 | $2.43K | 0.00% |
| Assetmark, Inc | 81 | $1.22K | 0.00% |
Sold out (4)
Institutions that held Forte Biosciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Heights Capital Management, Inc | 143,033 | $1.85M |
| Perceptive Advisors LLC | 68,192 | $881.7K |
| Boothbay Fund Management, LLC | 58,637 | $758.2K |
| Garde Capital, Inc. | 3,960 | $51.2K |